Going on Trial: Trofinetide approval for Rett; n-of-1 ASO therapies; cord-blood deals
Release Date:
This month’s issue of the Going on Trial newsletter examines personalized therapies for rare conditions, Acadia’s new drug for Rett syndrome and developments in a cord-blood program, among other autism-related drug trial news.
Going on Trial: Trofinetide approval for Rett; n-of-1 ASO therapies; cord-blood deals